References
- Hardy J G, Newman S P, Knoch M. Lung deposition from four nebulizers. Respir Med 1993; 87: 461
- Chua H L, Collis G G, Newbury A M, Chan K, Bower G D, Sly P D, Le Souef P N. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994; 7: 2185
- Nikander K, Turpeinen M, Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med 1999; 12: 47
- Smaldone G C, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998; 11: 113
- Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulized budesonide in pre-school children. Arch Dis Child 1999; 80: 241
- Everard M L, Clark A R, Milner A D. Drug delivery from jet nebulisers. Arch Dis Child 1992; 67: 586
- Lodrup Carlsen K C, Nikander K, Carlsen K-H. How much nebulised budesonide reaches infants and toddlers. Arch Dis Child 1992; 67: 1077
- Nikander K, Bisgaard H. The impact of constant and breath-synchronized nebulization on the inhaled mass of nebulized budesonide in infants and children. Pediatr Pulmonol 1999; 28: 187
- Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Saunders, Philadelphia 1971
- Nikander K. Some technical, physico-chemical and physiological aspects on nebulization of drug. Eur Respir Rev 1997; 7: 44, 168
- Muers M F, Ahmedzai S, Barry P. Current best practice for nebuliser treatment: introduction. Thorax 1997; 52: S1, Suppl 2